Robert Lilley

CurveBeam AI Limited | Non-Executive Chairman, Non-Executive Director

Mr Lilley has over 35 years of experience in the medical device and diagnostics industries. He previously served as senior vice president of global sales and marketing for Digene Corporation, a molecular diagnostics company later acquired by Qiagen N.V. He is currently the Chair of Immunexpress Pty Ltd, an Australian molecular diagnostics company. He is also member of Risk committee.

Company and Roles

Company	Title	Tenure	Since
CVB CurveBeam AI Limited	Non-Executive Chairman Non-Executive Director	5yrs, 3mth	Apr 2021

Holding

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
CVB CurveBeam AI Limited	01/07/26	3,667,486	N/A	1,926,736	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
CVB CurveBeam AI Limited	01/07/26	Buy	127,836	$0.025	$3,195	Conversion of securities
CVB CurveBeam AI Limited	01/07/26	Exercise	127,836	$0.025	$3,195	Conversion of securities
CVB CurveBeam AI Limited	14/08/25	Issued	63,918	$0.196	$12,499	Conversion of securities
CVB CurveBeam AI Limited	14/08/25	Exercise	63,918	$0.196	$12,499	Conversion of securities
CVB CurveBeam AI Limited	24/03/25	Buy	82,148	$0.259	$21,250	Conversion of securities

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in